Bookmark and Share
(4-([1,1'-Biphenyl]-4-yl)-2H-1,2,3-triazol-2-yl)(pyrrolidin-1-yl)methanone (CID 56593029) - Compound BioActivity Data
.
BioActivity Outcomes:
Probe(1)
 
 
Active(9)
 
 
Inactive(50)
 
 
Unspecified(5)
 
 
Top Targets:
PAF-AH p II(10)
 
 
 
 
Peptidase S9(7)
 
 
Hydrolase 4(6)
 
 
Peptidase S9(5)
 
 
Abhydrolase 2(2)
 
 
BioAssay Types:
Confirmatory(5)
 
 
 
Summary(4)
 
 
 
BioActivity Types:
IC50(3)
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 11    Data Row: 65   Total Pages: 2   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103913572]
Summary of the probe development efforts to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) [AID492969, Type: summary]platelet-activating factor acetylhydrolase 2, cytoplasmic [Homo sapiens] [gi:4758878]
View
2
[SID103913572]
IC50 0.003Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: Fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) IC50 [AID504494, Type: confirmatory]platelet-activating factor acetylhydrolase 2, cytoplasmic isoform b [Mus musculus] [gi:225579137]
View
3
[SID103913572]
IC50 170Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: fluorescence-based cell-based gel-based Activity-Based Protein Profiling (ABPP) IC50 [AID504496, Type: confirmatory]platelet-activating factor acetylhydrolase 2, cytoplasmic isoform b [Mus musculus] [gi:225579137]
View
4
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: Fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) inhibition and selectivity [AID504513_1, Type: other]platelet-activating factor acetylhydrolase 2, cytoplasmic isoform b [Mus musculus] [gi:225579137]
View
5
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_1, Type: other]platelet-activating factor acetylhydrolase 2, cytoplasmic isoform b [Mus musculus] [gi:225579137]
View
6
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: fluorescence-based cell-based gel-based Activity-Based Protein Profiling (ABPP) inhibition [AID504495, Type: other]platelet-activating factor acetylhydrolase 2, cytoplasmic isoform b [Mus musculus] [gi:225579137]
View
7
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS/MS assay to assess binding of compounds to active site [AID504486, Type: other]unnamed protein product [Homo sapiens] [gi:189054044]
View
8
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: Fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) inhibition and selectivity [AID504513, Type: other]
View
9
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519, Type: other]
View
10
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: Fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) assay to assess selectivity against anti-target pPAFAH in situ [AID504531, Type: other]
View
11
[SID103913572]
IC50 [AID 504494] 0.003Summary of the probe development efforts to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) [AID492969_1, Type: summary]platelet-activating factor acetylhydrolase 2, cytoplasmic isoform b [Mus musculus] [gi:225579137]
View
12
[SID103913572]
CC50 [AID 504511_1] 35Summary of the probe development efforts to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) [AID492969_2, Type: summary]
View
13
[SID103913572]
CC50 [AID 504511_2] 50Summary of the probe development efforts to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) [AID492969_3, Type: summary]
View
14
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: Fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) assay to assess selectivity against anti-target pPAFAH in situ [AID504531_1, Type: other]platelet-activating factor acetylhydrolase 2, cytoplasmic isoform b [Mus musculus] [gi:225579137]
View
15
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: Fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) assay to assess selectivity against anti-target pPAFAH in situ [AID504531_2, Type: other]Phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) [Mus musculus] [gi:14715116]
View
16
[SID103913572]
35Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: absorbance-based cell-based dose response assay to determine cytotoxicity of inhibitor compounds [AID504511_1, Type: confirmatory]
View
17
[SID103913572]
50Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: absorbance-based cell-based dose response assay to determine cytotoxicity of inhibitor compounds [AID504511_2, Type: confirmatory]
View
18
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: absorbance-based cell-based dose response assay to determine cytotoxicity of inhibitor compounds [AID504511, Type: confirmatory]
View
19
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_34, Type: other]dipeptidyl peptidase 9 [Mus musculus] [gi:255003757]
View
20
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_16, Type: other]alpha/beta hydrolase domain-containing protein 13 [Mus musculus] [gi:299473802]
View
21
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: Fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) counterscreen assay to assess selectivity against anti-target pPAFAH in vitro [AID504483, Type: other]phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) [Mus musculus] [gi:168984061]
View
22
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of diacylglycerol lipase, beta (DAGLb): fluorescence-based biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) inhibition of overexpressed DAGLb in vitro; triazole urea library [AID602303, Type: other]sn1-specific diacylglycerol lipase beta [Mus musculus] [gi:31559956]
View
23
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: Fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) inhibition and selectivity [AID504513_2, Type: other]Apeh protein, partial [Mus musculus] [gi:20072022]
View
24
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_4, Type: other]Apeh protein, partial [Mus musculus] [gi:20072022]
View
25
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_2, Type: other]Abhydrolase domain containing 6 [Mus musculus] [gi:20073260]
View
26
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_18, Type: other]platelet-activating factor acetylhydrolase isoform Ib beta subunit [Mus musculus] [gi:1373363]
View
27
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_41, Type: other]patatin-like phospholipase domain-containing protein 7 [Mus musculus] [gi:225007615]
View
28
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_30, Type: other]platelet-activating factor acetylhydrolase IB subunit gamma [Mus musculus] [gi:6679201]
View
29
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_23, Type: other]Prepl protein [Mus musculus] [gi:13435484]
View
30
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_22, Type: other]Family with sequence similarity 108, member C [Mus musculus] [gi:17391206]
View
31
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_12, Type: other]Acyl-CoA thioesterase 1 [Mus musculus] [gi:20380528]
View
32
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_39, Type: other]Ddhd1 protein [Mus musculus] [gi:27694042]
View
33
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_14, Type: other]isoamyl acetate-hydrolyzing esterase 1 homolog [Mus musculus] [gi:27754071]
View
34
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_27, Type: other]abhydrolase domain-containing protein 16A [Mus musculus] [gi:30519896]
View
35
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_9, Type: other]protein phosphatase methylesterase 1 [Mus musculus] [gi:30794138]
View
36
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_37, Type: other]Prcp protein [Mus musculus] [gi:32967631]
View
37
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_42, Type: other]Pnpla6 protein [Mus musculus] [gi:34784201]
View
38
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_3, Type: other]Pla2g6 protein [Mus musculus] [gi:34784362]
View
39
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_35, Type: other]Abhydrolase domain containing 10 [Mus musculus] [gi:37231537]
View
40
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_31, Type: other]Dipeptidylpeptidase 8 [Mus musculus] [gi:37590654]
View
41
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_15, Type: other]Acyl-CoA thioesterase 2 [Mus musculus] [gi:39992610]
View
42
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: Fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) inhibition and selectivity [AID504513_3, Type: other]Abhydrolase domain containing 11 [Mus musculus] [gi:47682716]
View
43
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_38, Type: other]Abhydrolase domain containing 11 [Mus musculus] [gi:47682716]
View
44
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_32, Type: other]Arylacetamide deacetylase-like 1 [Mus musculus] [gi:52139053]
View
45
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_8, Type: other]Family with sequence similarity 108, member A [Mus musculus] [gi:52789434]
View
46
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: Fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) inhibition and selectivity [AID504513_4, Type: other]Esterase D/formylglutathione hydrolase [Mus musculus] [gi:55777188]
View
47
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_5, Type: other]Esterase D/formylglutathione hydrolase [Mus musculus] [gi:55777188]
View
48
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_13, Type: other]Fam108b protein [Mus musculus] [gi:61403362]
View
49
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: Fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) inhibition and selectivity [AID504513_5, Type: other]Lypla1 [Mus musculus] [gi:71059731]
View
50
[SID103913572]
Late stage assay provider results from the probe development effort to identify inhibitors of PAFAH2: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for PAFAH2 [AID504519_24, Type: other]Lypla1 [Mus musculus] [gi:71059731]
View